Watch Ticker

Cogent Biosciences, Inc. Common Stock

Go to Cogent Biosciences, Inc. Common Stock Website

$11.36

0.00 (0.00%)

Live

Previous Close

$11.36

Day Range

$0 - $0

Previous Day Range

$11.33 - $12.02

Market Cap

$1.7 billion USD

Day Vol.

Previous Day Vol.

2.5 million

Currency

USD

Primary Exchange

Nasdaq

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its progr...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Christi Waarich - Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock

Cogent Biosciences plans to raise approximately $200 million through a public offering of 22,222,223 common stock shares at $9.00 per share, with proceeds intended for product development and corporate purposes.

Related tickers: COGT.

Read Full Article

Delveinsight - Gastrointestinal Stromal Tumor Market to Grow Rapidly During the Study Period (2020–2034) Owing to the Launch of Emerging Therapies | DelveInsight

The gastrointestinal stromal tumor (GIST) market is expected to grow rapidly due to the launch of emerging therapies and increased healthcare spending globally. Key companies working on GIST treatments include Cogent Biosciences, IDRx, Deciphera Pharmaceuticals, and others.

Related tickers: COGT.

Read Full Article

Trending Tickers

Please sign in to view